Reuters logo
7 months ago
BRIEF-UCB and Amgen seek marketing approval of romosozumab in Japan
December 20, 2016 / 6:18 AM / 7 months ago

BRIEF-UCB and Amgen seek marketing approval of romosozumab in Japan

1 Min Read

Dec 20 (Reuters) - UCB SA :

* Says Amgen and UCB announce submission of application for investigational osteoporosis medication romosozumab in Japan

Source text for Eikon: Further company coverage:

Gdynia Newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below